Transvascular Implantation of an Implantable Cardioverter-Defibrillator in a Patient Who has Undergone One-and-a-Half Ventricle Repair
Implantable cardioverter-defibrillator (ICD) therapy is acknowledged as a valid treatment method for the effective prevention of sudden cardiac death, which is a major cause of mortality in adult congenital heart disease patients. But ICD implantation by the conventional transvascular approach is no...
Saved in:
Published in | Korean circulation journal Vol. 45; no. 4; pp. 344 - 347 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Korea (South)
The Korean Society of Cardiology
01.07.2015
대한심장학회 |
Subjects | |
Online Access | Get full text |
ISSN | 1738-5520 1738-5555 |
DOI | 10.4070/kcj.2015.45.4.344 |
Cover
Loading…
Summary: | Implantable cardioverter-defibrillator (ICD) therapy is acknowledged as a valid treatment method for the effective prevention of sudden cardiac death, which is a major cause of mortality in adult congenital heart disease patients. But ICD implantation by the conventional transvascular approach is not always possible in patients who have undergone palliative surgery due to congenital and structural heart disease. Here, we report a case in which an ICD was transvascularly implanted in an arrhythmogenic right ventricular cardiomyopathy patient who had undergone a one-and-a-half ventricle repair. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 G704-000708.2015.45.4.012 |
ISSN: | 1738-5520 1738-5555 |
DOI: | 10.4070/kcj.2015.45.4.344 |